Wenbin Wan

ORCID: 0000-0002-2502-0177
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alzheimer's disease research and treatments
  • Advanced Glycation End Products research
  • Barrier Structure and Function Studies
  • Peripheral Neuropathies and Disorders
  • Endoplasmic Reticulum Stress and Disease
  • Autophagy in Disease and Therapy
  • S100 Proteins and Annexins
  • Parkinson's Disease Mechanisms and Treatments
  • Mesenchymal stem cell research
  • Antifungal resistance and susceptibility
  • GDF15 and Related Biomarkers
  • Myasthenia Gravis and Thymoma
  • Wnt/β-catenin signaling in development and cancer
  • Complement system in diseases
  • Computational Drug Discovery Methods
  • Neurological disorders and treatments
  • Heat shock proteins research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Diabetic Foot Ulcer Assessment and Management
  • Heavy Metal Exposure and Toxicity
  • Intracranial Aneurysms: Treatment and Complications
  • Sirtuins and Resveratrol in Medicine
  • Pluripotent Stem Cells Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Ship Hydrodynamics and Maneuverability

Shanghai Jiao Tong University
2018-2025

Renji Hospital
2018-2024

Fudan University
2013-2019

Zhongshan Hospital
2014-2019

State Key Laboratory of Medical Neurobiology
2019

Sun Yat-sen University
2014-2018

The First Affiliated Hospital, Sun Yat-sen University
2014-2018

Naval University of Engineering
2015

Huadong Hospital
2014

Affiliated Hospital of Zunyi Medical College
2004-2009

Growing evidence has indicated that iron deposition in the substantia nigra (SN) plays an important role Parkinson's disease (PD). However, underlying mechanism is still elusive. Using primary dopaminergic neurons and SH-SY5Y cells cultured vitro, we observed loading increased α-synuclein reactive oxygen species (ROS) levels these but did not affect intracellular mRNA levels. Furthermore, significantly downregulated Beclin-1 decreased ratio of microtubule-associated protein 1 light chain 3...

10.3389/fneur.2017.00001 article EN cc-by Frontiers in Neurology 2017-01-15

Abstract Accumulating evidence indicates that abnormal deposition of amyloid‐β (Aβ) peptide in the brain is responsible for endothelial cell damage and consequently leads to blood–brain barrier ( BBB ) leakage. However, mechanisms underlying disruption are not well described. We employed an monolayer model comprising bE nd.3 found leakage was induced by treatment with Aβ 1–42, levels tight junction TJ scaffold proteins ZO ‐1, Claudin‐5, Occludin) were decreased. Through comparisons effects...

10.1111/jnc.13122 article EN Journal of Neurochemistry 2015-04-11

Neuromelanin of the brainstem, which is considered a marker neurodegeneration in Parkinson's disease (PD), can be detected by T1-weighted neuromelanin-sensitive magnetic resonance imaging (NM-MRI). Our aim was to investigate NM-MRI features de novo PD and determine whether these are associated with motor non-motor symptoms patients.Fifty-one patients (Hoehn Yahr stage 1-2) 28 healthy controls were recruited. All subjects underwent clinical MRI examinations including an sequence. The width...

10.1111/ene.13628 article EN European Journal of Neurology 2018-03-09

Iron deposition in the brain is an early issue Alzheimer's disease (AD). However, pathogenesis of iron-induced pathological changes AD remains elusive. Insulin resistance brains essential feature AD. Previous studies determined that insulin involved development pathologies Tau pathology one most important hallmarks and associated with impairment cognition clinical grades disease. In present study, we observed ferrous (Fe2+) chloride led to aberrant phosphorylation tau, decreased tyrosine...

10.3389/fneur.2019.00607 article EN cc-by Frontiers in Neurology 2019-06-19

Alzheimer's disease (AD) is the most common form of senile dementia which characterized by abnormal amyloid beta (Aβ) accumulation and deposition in brain parenchyma cerebral capillaries, leads to blood-brain barrier (BBB) disruption. Despite great progress understanding etiology AD, underlying pathogenic mechanism BBB damage still unclear, no effective treatment has been devised. The standard Ginkgo biloba extract EGb761 widely used as a potential cognitive enhancer for AD. However,...

10.1371/journal.pone.0113126 article EN cc-by PLoS ONE 2014-11-26

The objective of the present study was to investigate optimal culture requirements for mycelial growth and exopolysaccharide production by Cordyceps jiangxiensis JXPJ 0109 in submerged culture.The effects medium ingredients (i.e. carbon nitrogen sources, factor) other initial pH, temperature, etc.) on mycelia were observed using a one-factor-at-a-time method. More suitable proved be maltose, glycerol, tryptone, soya bean steep powder, yeast extract, capacity 200 ml 500-ml flask, agitation...

10.1111/j.1365-2672.2004.02235.x article EN Journal of Applied Microbiology 2004-04-08

Autoimmune encephalitis (AE) is a group of disorders characterized by antibodies targeting neuronal cell surface, intracellular structures and synapse antigens. Treatment for AE involves reducing antibody levels suppressing immune-mediated inflammation using intravenous immunoglobulin, plasma exchange (PE), immune-modulating agents. PE commonly used in autoimmune neurological diseases, but the safety issues are worth continuous attention. This case report describes 28-year-old patient who...

10.3389/fcvm.2025.1574698 article EN cc-by Frontiers in Cardiovascular Medicine 2025-04-10

Alzheimer's disease (AD) is the most common type of dementia and has no effective therapies. Previous studies showed that bone morphogenetic protein 9 (BMP9), an important factor in differentiation phenotype maintenance cholinergic neurons, ameliorated defects resulting from amyloid deposition. These findings suggest BMP9 potential as a therapeutic agent for AD. However, effects on cognitive function AD its underlying mechanisms remain elusive. In present study, was delivered intranasally to...

10.3389/fnmol.2017.00032 article EN cc-by Frontiers in Molecular Neuroscience 2017-02-07
Coming Soon ...